Business Wire: Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin
Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin
Frontiers: Immunometabolism and Molecular Signaling in Systemic Inflammation: Connecting Acute Stress to Chronic Diseases
Immunometabolism and Molecular Signaling in Systemic Inflammation: Connecting Acute Stress to Chronic Diseases
Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...
Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since ...
Frontiers: Lifestyle-driven low-grade inflammation: Immunometabolic, hormonal and microenvironmental determinants across chronic inflammatory diseases
Chronic inflammatory diseases have traditionally been investigated as distinct clinical entities. However, growing evidence indicates that many of these ...
Lifestyle-driven low-grade inflammation: Immunometabolic, hormonal and microenvironmental determinants across chronic inflammatory diseases
Inflammation is a complex biochemical reaction in the body. When short lived, it can be life saving. But, when inflammatory responses become persistent or chronic, it can quietly damage tissues and ...
In recent years, there's been a growing awareness of neuroinflammation, an immune response in the brain. Research suggests that chronic inflammatory activation could be a central driver behind many ...
A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.